OA Online

EVIO Biosciences Launches the World's First Genomics Testing Program for Pathogen Identification in Cannabis

By The Associated Press

October 25, 2018

“BEND, Ore.--(BUSINESS WIRE)--Oct 24, 2018--EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, is excited to announce EVIO Biosciences launches the release of the first Genomics Testing program for Pathogen Identification in Cannabis. The EVIO Biosciences division launched in May led by EVIO’s Chief Science Officer, Dr. Anthony Smith.”

Read more here>>>>

 

source link:

https://www.oaoa.com/news/business/article_c68748f9-5c6c-5e90-a00a-a73f435b743d.html